|
|
|
Insider
Information: |
Bvf Inc/il |
Relationship: |
Indirect Beneficial Ow... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
49,829,941 |
|
Indirect Shares
|
136,880,248 |
|
|
Direct
Value |
$2,490,637,717 |
|
|
Indirect Value
|
$7,464,070,827 |
|
|
Total
Shares |
186,710,189 |
|
|
Total
Value |
$9,954,708,545 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
2
|
Stock
price went up :
|
18
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
18.0
|
-2.0
|
Percentage
Gain/Loss : |
64.8%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
2010-04-12 |
5,041,447 |
2010-04-12 |
15,124,341 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Indirect Beneficial Ow... |
2008-03-11 |
0 |
2008-09-22 |
4,383,115 |
Premium* |
|
Astex Pharmaceuticals Inc |
ASTX |
Indirect Beneficial Ow... |
2008-05-01 |
0 |
2008-05-09 |
5,753,399 |
Premium* |
|
Neurobiological Technologies Inc |
NTII |
10% Owner |
2009-10-21 |
331,998 |
2009-10-21 |
995,994 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
2009-12-22 |
6,830,972 |
2009-12-22 |
20,492,916 |
Premium* |
|
Capstone Therapeutics Corp |
CAPS |
Indirect Beneficial Ow... |
2008-10-10 |
0 |
2008-10-14 |
5,136,888 |
Premium* |
|
Adolor Corp |
ADLR |
Indirect Beneficial Ow... |
2008-10-10 |
4,428,032 |
2008-10-31 |
6,214,551 |
Premium* |
|
Dynavax Technologies Corp |
DVAX |
10% Owner |
2009-09-10 |
4,278,851 |
2009-09-10 |
12,836,553 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Indirect Beneficial Ow... |
2009-07-01 |
15,169,950 |
2009-07-01 |
45,509,850 |
Premium* |
|
Curis Inc |
CRIS |
Indirect Beneficial Ow... |
2009-02-03 |
8,921,716 |
2009-04-27 |
5,951,716 |
Premium* |
|
Repligen Corp |
RGEN |
Indirect Beneficial Ow... |
2009-07-07 |
2,765,050 |
2009-07-07 |
8,295,150 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Indirect Beneficial Ow... |
2009-10-16 |
2,061,925 |
2009-10-16 |
6,185,775 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
195 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2009-01-20 |
4 |
B |
$3.08 |
$231,135 |
I/I |
75,000 |
5,905,447 |
1.5 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-22 |
4 |
B |
$3.24 |
$231,372 |
I/I |
71,400 |
4,577,832 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-12-01 |
4 |
B |
$2.35 |
$233,173 |
I/I |
99,400 |
5,812,447 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-11 |
4 |
B |
$1.39 |
$233,429 |
I/I |
167,850 |
10,252,798 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-02-29 |
4 |
B |
$4.99 |
$236,706 |
I/I |
47,400 |
3,960,500 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Direct Beneficial Owner |
|
2010-03-24 |
4 |
S |
$2.75 |
$242,334 |
D/D |
(88,000) |
5,757,547 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-12-01 |
4 |
B |
$1.86 |
$245,476 |
I/I |
131,700 |
13,191,953 |
1.5 |
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
Indirect Beneficial Owner |
|
2008-07-08 |
4 |
B |
$2.99 |
$245,799 |
I/I |
82,100 |
4,291,674 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-02-15 |
4 |
B |
$5.08 |
$252,072 |
I/I |
49,600 |
7,863,177 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Direct Beneficial Owner |
|
2010-04-09 |
4 |
S |
$2.76 |
$259,290 |
D/D |
(94,000) |
5,145,447 |
0 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-05-01 |
4 |
S |
$2.84 |
$263,720 |
I/I |
(93,000) |
5,779,900 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-10 |
4 |
B |
$1.36 |
$270,072 |
I/I |
198,000 |
10,084,948 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-14 |
4 |
B |
$1.30 |
$273,050 |
I/I |
210,000 |
10,571,309 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Direct Beneficial Owner |
|
2010-03-30 |
4 |
S |
$2.70 |
$280,852 |
D/D |
(104,000) |
5,240,447 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-06-28 |
4 |
S |
$5.30 |
$287,010 |
I/I |
(54,000) |
1,476,351 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-24 |
4 |
B |
$2.01 |
$287,573 |
I/I |
143,000 |
11,116,653 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Direct Beneficial Owner |
|
2010-04-12 |
4 |
S |
$2.80 |
$291,398 |
D/D |
(104,000) |
5,041,447 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-01-21 |
4 |
S |
$6.00 |
$297,000 |
I/I |
(49,500) |
1,556,351 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-21 |
4 |
B |
$1.78 |
$331,751 |
I/I |
186,744 |
10,973,653 |
1.5 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-07-08 |
4 |
S |
$5.00 |
$334,000 |
I/I |
(66,800) |
994,851 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-12-02 |
4 |
B |
$1.90 |
$365,928 |
I/I |
193,000 |
13,384,953 |
1.5 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-06-29 |
4 |
S |
$5.31 |
$376,797 |
I/I |
(71,000) |
1,441,351 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-02-22 |
4 |
B |
$4.84 |
$382,313 |
I/I |
79,000 |
3,419,300 |
1.5 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-03-14 |
4 |
B |
$3.84 |
$384,450 |
I/I |
100,000 |
4,809,015 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-02-11 |
4 |
B |
$4.96 |
$414,851 |
I/I |
83,700 |
7,813,577 |
1.5 |
- |
|
195 Records found
|
|
Page 5 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|